EURAZEO (EPA:RF) | Finanzwire

Basculer en Français

8295	Companies
114831	Keywords
55272	Articles
62429	Press releases

Home
Companies
EURAZEO

REGULATED PRESS RELEASE

published on 11/18/2024 at 17:35, 2 days 16 hours ago

Disclosure of transactions in own shares on November 11 to November 15, 2024
REGULATED PRESS RELEASE

published on 11/12/2024 at 17:35, 8 days 16 hours ago

Disclosure of transactions in own shares on November 1 to November 8, 2024
BRIEF

published on 11/08/2024 at 17:40, 12 days 16 hours ago

EURAZEO's Voting Rights and Share Capital Information for October 2024

Share Capital Voting Rights Regulatory Compliance EURAZEO AMF
REGULATED PRESS RELEASE

published on 11/08/2024 at 17:35, 12 days 16 hours ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2024
Disclosure of the number of shares and voting rights by Eurazeo SE as of October 31, 2024 in compliance with French regulations. Eurazeo is a leading European investment group managing diversified assets

Voting Rights Shares Investment Group Eurazeo SE Assets
BRIEF

published on 11/06/2024 at 07:05, 15 days 3 hours ago

Eurazeo Achieves Strong Growth and Realizations in 2024

Portfolio Performance Asset Management Impact Investments Fundraising Growth Realizations Increase
REGULATED PRESS RELEASE

published on 11/06/2024 at 07:00, 15 days 3 hours ago

EURAZEO RECORDS DYNAMIC ASSET MANAGEMENT GROWTH AND A PICK-UP IN REALIZATIONS IN THE FIRST 9 MONTHS OF 2024, IN LINE WITH ITS STRATEGIC PLAN
Eurazeo reports dynamic asset management growth with €3bn fundraising (+76%) and pick-up in realizations. Strong portfolio company performance reflected in revenue growth. Progress in ESG and impact investments

EURAZEO Asset Management Fundraising ESG Realizations
REGULATED PRESS RELEASE

published on 10/31/2024 at 18:19, 20 days 16 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
REGULATED PRESS RELEASE

published on 10/28/2024 at 17:35, 23 days 16 hours ago

Disclosure of transactions in own shares on October 21 to October 25, 2024
REGULATED PRESS RELEASE

published on 10/21/2024 at 17:35, 30 days 16 hours ago

Disclosure of transactions in own shares on October 14 to October 18, 2024
REGULATED PRESS RELEASE

published on 10/14/2024 at 17:35, 1 month 6 days ago

Disclosure of transactions in own shares on October 7 to October 11, 2024

Accesswire

Published on 11/21/2024 at 10:03, 30 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 33 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 33 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 9 hours 58 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 8 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:04, 28 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 31 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 33 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 33 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 32 minutes ago

Original-Research: Netfonds AG (von NuWays AG): Buy

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 48 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 48 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE